4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant.

Name: 4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant.
Creator: National Library of Medicine
Published: 2026-06-21T06:45:09+08:00

Food and Nutrition Information Center2026-06-21 收录

药品标签合规

药物监管执法

数据链接：

https://fdanj.nlm.nih.gov/catalog/ddnj04122 数据链接链接失效反馈

官方服务：

资源简介：

Case Number: 4122 Collection: Drugs and Devices, 1940-1963 Evidence Numbers: F. D. C. No. 34841. Sample Nos. 46279-L to 46283-L, incl. , 46285-L. Date Issued: June 1954 Seizure Dates: July 18, 21, 26, 28, and 29, 1952 Product Keywords: dextro-amphetamine sulfate tablets and secobarbital sodium capsules Defendant Names: Clyde King, trading as the Clyde King Drug Co., Birmingham, Ala., and Benjamin H. Darnell, a pharmacist for the company. Court Jurisdiction: Northern District of Alabama Seizure Location: Birmingham, Ala. Shipped From: Birmingham, Ala. Shipped To: Birmingham, Ala. Copyright: The National Library of Medicine believes this item to be in the public domain (More information)

提供机构：

National Library of Medicine

4122. Misbranding of dextro-amphetamine sulfate tablets and secobarbital sodium capsules. U. S. v. Clyde King (Clyde King Drug Co.), and Benjamin H. Darnell. Pleas of guilty. Fine of $50 against each defendant.

资源简介：

相关数据集